We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$118M
AUM Growth
-$12M
Cap. Flow
-$24.6M
Cap. Flow %
-20.81%
Top 10 Hldgs %
43.16%
Holding
94
New
22
Increased
10
Reduced
13
Closed
18

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.61M
2
XNPT
XENOPORT, INC.
XNPT
+$2.71M
3
ACHN
Achillion Pharmaceuticals
ACHN
+$2.26M
4
OTIC
Otonomy, Inc.
OTIC
+$1.72M
5
CYAD
Celyad Oncology SA American Depositary Shares
CYAD
+$1.61M

Top Sells

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$18.3M
2
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$12.1M
3
MTEM
Molecular Templates, Inc.
MTEM
+$2.54M
4
ATRC icon
AtriCure
ATRC
+$1.98M
5
CRIS icon
Curis
CRIS
+$720K

Sector Composition

Rank Sector Weight
1 Healthcare 72.51%
2 Financials 0.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CUTR
76
DELISTED
Cutera, Inc.
CUTR
– –
-23,490
Closed -$303K
ACER
77
DELISTED
Acer Therapeutics Inc
ACER
– –
-6
Closed –
MTEM
78
DELISTED
Molecular Templates, Inc.
MTEM
– –
-3,791
Closed -$2.54M
APEN
79
DELISTED
Apollo Endosurgery, Inc.
APEN
– –
-1,453
Closed -$276K
EPZM
80
DELISTED
Epizyme, Inc
EPZM
– –
-20,000
Closed -$376K
KERX
81
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-34,800
Closed -$443K
GBIM
82
DELISTED
GLOBEIMMUNE INC COM STK (DE)
GBIM
– –
-9,445
Closed -$69K
NSPH
83
DELISTED
NANOSPHERE INC. COM NEW
NSPH
– –
-30,000
Closed -$139K
PCYC
84
DELISTED
PHARMACYCLICS INC
PCYC
– –
-71,628
Closed -$18.3M
ASPX
85
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
– –
-120,500
Closed -$12.1M
RXII
86
DELISTED
GALENA BIOPHARMA INC COM
RXII
– –
-250,000
Closed -$348K
1 2 3
4

Similar funds

CDMG
Creek Drive Management Group San Francisco, California $439M AUM
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM

DAFNA Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, DAFNA Capital Management held 94 positions worth $118M, down 9.2% from $130M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

DAFNA Capital Management withdrew a net $24.6M in Q2 2015, closing 18 positions and reducing 13 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 56% a quarter earlier, followed by Financials.

Against the trend, DAFNA Capital Management opened a new position in AbbVie worth $7.83M.

  • DAFNA Capital Management's largest Q2 2015 buy was AbbVie: 116,581 shares worth $7.83M.
  • DAFNA Capital Management added most to XENOPORT, INC. in Q2 2015, an estimated $2.71M increase.
  • DAFNA Capital Management's biggest Q2 2015 reduction was AtriCure, cutting an estimated $1.98M.
  • DAFNA Capital Management fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $18.3M.
  • DAFNA Capital Management's ten largest holdings make up 43% of its $118M portfolio in Q2 2015.
  • DAFNA Capital Management opened 22 new positions and closed 18 in Q2 2015.
  • DAFNA Capital Management's portfolio value fell 9.2% quarter-over-quarter to $118M.

Based on DAFNA Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.